Recommendation ID
NICE recommends that studies directly comparing different epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation test methods are performed. These studies should include the re-testing of stored non-small-cell lung cancer (NSCLC) tumour samples using different EGFR-TK mutation test methods and should link to patient outcomes.
Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer
Date issued
August 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 06/09/2013